AI assistant
Sending…
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2017
May 25, 2017
32163_dirs_2017-05-25_73b532d0-23ab-4c43-947b-f5186d3d7cdb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2017-05-24
Reporting Person: SANTINI GINO (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-24 | Stock Option (Right to Purchase) | $9.33 | A | 19853 | Acquired | 2027-05-24 | Common Stock (19853) | Direct |
Footnotes
F1: The option vests and becomes exercisable on May 24, 2018, subject to the director's continued service with the issuer.
More from COLLEGIUM PHARMACEUTICAL, INC
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Annual Report
2026
Feb 26